- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
SLC22A8 Antibody / OAT3 recognizes Solute Carrier Family 22 Member 8, more commonly known as Organic Anion Transporter 3 (OAT3), a multispecific membrane transporter involved in the uptake and excretion of a broad range of endogenous metabolites, drugs, toxins, and signaling molecules. OAT3 is predominantly expressed in the basolateral membrane of renal proximal tubule epithelial cells, where it plays a central role in renal secretion and systemic clearance of organic anions. Through its transport activity, OAT3 contributes to the elimination of numerous pharmaceutical compounds, making it an important target in nephrology, pharmacology, and drug development research.
As a member of the SLC22 transporter family, OAT3 functions in concert with other renal transporters to regulate the movement of organic solutes between blood and urine. Substrates transported by OAT3 include urate, prostaglandins, cyclic nucleotides, steroid conjugates, antibiotics, antiviral agents, diuretics, and a variety of xenobiotic compounds. Because OAT3 influences drug disposition and renal drug clearance, alterations in SLC22A8 expression or function can significantly affect pharmacokinetics, therapeutic efficacy, and susceptibility to drug-induced nephrotoxicity. Researchers frequently investigate OAT3 expression in studies of kidney physiology, transporter-mediated drug interactions, and renal disease mechanisms.
OAT3 is also implicated in broader physiological processes beyond renal excretion. Expression has been reported in additional tissues including the choroid plexus, brain, and vascular structures, where the transporter may contribute to metabolite homeostasis and regulation of signaling molecules. Changes in SLC22A8 expression have been associated with kidney injury, chronic kidney disease, inflammation, and altered metabolic states. Consequently, OAT3 has emerged as a valuable biomarker and research target for understanding transporter regulation, renal pathology, and mechanisms underlying drug toxicity and resistance.
SLC22A8 / OAT3 Antibody is useful for investigating renal transport pathways, membrane transporter biology, drug disposition, and nephrotoxicity-associated signaling networks. The antibody may be applied in studies examining transporter localization, tissue-specific expression, and regulation under physiological or pathological conditions. Common search terms including SLC22A8 antibody, OAT3 antibody, Organic Anion Transporter 3 antibody, renal transporter antibody, and kidney drug transporter antibody further reflect the broad scientific interest in this target across multiple research disciplines.
NSJ Bioreagents offers SLC22A8 / OAT3 Antibody to support studies of renal physiology, transporter-mediated drug handling, nephrology, pharmacokinetics, and cellular transport mechanisms. By enabling detection of this important organic anion transporter, the antibody provides researchers with a valuable tool for investigating kidney function, transporter biology, and drug transport pathways.
Researchers studying membrane transporters, renal physiology, drug disposition, and metabolite handling may also be interested in our Metabolism Antibodies landing page featuring targets involved in cellular transport, energy regulation, and metabolic homeostasis.
Optimal dilution of the SLC22A8 / OAT3 antibody should be determined by the researcher.
E. coli-derived recombinant human protein (amino acids M1-Q470) was used as the immunogen for the SLC22A8 / OAT3 antibody.
After reconstitution, the SLC22A8 / OAT3 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
SLC22A8 antibody, OAT3 antibody, Solute carrier family 22 member 8 antibody, Organic anion transporter 3 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.